Novel (heterocycle/tetrahydropyridine)-(piperazinyl)-1-alcanone and (heterocycle/dihydropyrrolidine)-(piperazinyl)-1-alcanone derivatives, and use thereof as p75 inhibitors

Details for Australian Patent Application No. 2010338111 (hide)

Owner Sanofi

Inventors Baroni, Marco; Bono, Francoise; Delbary-Gossart, Sandrine; Vercesi, Valentina

Agent A J Park

Pub. Number AU-A-2010338111

PCT Pub. Number WO2011/080445

Priority 09/06025 14.12.09 FR

Filing date 13 December 2010

Wipo publication date 7 July 2011

International Classifications

C07D 401/14 Heterocyclic compounds containing two or more hetero rings

A61K 31/496 - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61K 31/497

A61K 31/4995 - Pyrazines or piperazines forming part of bridged ring systems

A61K 31/506 - not condensed and containing further heterocyclic rings

A61K 31/551 - having two nitrogens as ring hetero atoms, e.g. clozapine, dilazep

A61P 25/00 Drugs for disorders of the nervous system

C07D 401/04 Heterocyclic compounds containing two or more hetero rings

C07D 403/14 Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 407/04 Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group

C07D 407/14 Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group

C07D 409/04 Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 409/14 Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 495/04 Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms

Event Publications

5 July 2012 PCT application entered the National Phase

  PCT publication WO2011/080445 Priority application(s): WO2011/080445

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010338115-Method for reducing the bacterial content of a food and/or biological medium of interest containing lipid droplets

2010338110-Novel (heterocycle/condensed piperidine)-(piperazinyl)-1-alcanone or (heterocycle/condensed pyrrolidine)-(piperazinyl)-1-alcanone derivatives, and use thereof as p75 inhibitors